Results
184
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
184 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EH | US$12.01 | -22.1% | -29.7% | US$760.1m | US$24.98 | PS35.2x | E74.3% | n/a | Capital Goods | ||
CRDO | US$29.50 | -10.8% | 80.2% | US$4.9b | US$30.33 | PS25.3x | E60.9% | n/a | Semiconductors | ||
ATAT | US$16.93 | -6.4% | -12.0% | US$2.3b | US$27.17 | PE17.4x | E22.1% | 0.9% | Consumer Services | ||
TBBB | US$26.01 | 3.8% | n/a | US$2.9b | US$26.84 | PS1.1x | E94.7% | n/a | Consumer Retailing | ||
PDD | US$133.04 | -3.6% | 68.7% | US$184.8b | US$207.21 | PE16.8x | E21.4% | n/a | Retail | ||
GCT | US$28.59 | -3.7% | 236.0% | US$1.2b | US$53.22 | PE11.1x | E25.2% | n/a | Retail | ||
VCTR | US$51.58 | -1.1% | 50.9% | US$3.3b | US$52.00 | PE15.2x | E34.0% | 2.9% | Diversified Financials | ||
CG | US$45.94 | 4.2% | 33.1% | US$16.5b | US$48.30 | PS7.5x | E23.6% | 3.0% | Diversified Financials | ||
SMCI | US$796.78 | -11.2% | 157.5% | US$46.7b | US$1,035.32 | PE44.5x | E40.2% | n/a | Tech | ||
BRDG | US$8.34 | 1.8% | -32.5% | US$1.0b | US$9.88 | PS1.1x | E98.2% | 7.9% | Diversified Financials | ||
DUOL | US$175.24 | -8.8% | 18.7% | US$7.6b | US$250.46 | PE165.7x | E48.1% | n/a | Consumer Services | ||
MAX | US$14.18 | 3.9% | 42.8% | US$933.7m | US$25.33 | PS1.8x | E88.1% | n/a | Media | ||
ZKH | US$3.39 | -7.4% | n/a | US$546.0m | US$15.74 | PB1.2x | E104.4% | n/a | Capital Goods | ||
LOOP | US$1.84 | -9.8% | -31.1% | US$87.5m | US$8.50 | PS662.7x | E78.8% | n/a | Materials | ||
EVOK | US$0.53 | -10.0% | -68.7% | US$4.6m | US$7.00 | PB1.3x | E110.6% | n/a | Pharmaceuticals & Biotech | ||
MDGL | US$287.24 | 2.6% | 39.7% | US$6.1b | US$365.33 | PB7.2x | E64.4% | n/a | Pharmaceuticals & Biotech | ||
HNVR | US$17.30 | 2.7% | -2.2% | US$125.4m | US$18.50 | PB0.7x | E20.9% | 2.3% | Banks | ||
MP | US$14.29 | -6.6% | -40.0% | US$2.4b | US$22.88 | PE705.4x | E62.0% | n/a | Materials | ||
SMWB | US$6.90 | -1.7% | -2.4% | US$554.2m | US$10.40 | PS2.5x | E107.1% | n/a | Software | ||
RYAN | US$57.27 | -1.3% | 27.2% | US$14.9b | US$60.08 | PE107.2x | E49.2% | 0.8% | Insurance | ||
WULF | US$5.59 | -6.8% | 63.9% | US$1.9b | US$6.46 | PS18.6x | E104.9% | n/a | Software | ||
HOFV | US$2.87 | -3.4% | -75.2% | US$18.7m | US$8.00 | PB0.2x | E71.1% | n/a | Consumer Services | ||
CARG | US$25.82 | -1.4% | 13.7% | US$2.7b | US$26.85 | PE74.2x | E29.2% | n/a | Media | ||
MYO | US$5.03 | 0.6% | 524.8% | US$144.9m | US$6.80 | PS7.4x | E69.5% | n/a | Healthcare |